Injectable botulinum toxin formulations
US9956435B2 · kind B2 · utility
10Cited by
3References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2009 |
| Grant date | May 1, 2018 |
| Priority date | — |
| Expiry date | Jan 3, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the invention exhibit one or more advantages over conventional botulinum toxin formulations, including reduced antigenicity, a reduced tendency to undergo unwanted localized diffusion following injection, increased duration of clinical efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or improved stability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.